Next Generation Immunotherapy Market – Industry Trends and Forecast to 2029
MarkNtel Advisors, a prominent market research firm, has recently published a report titled Next Generation Immunotherapy Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2029. This study offers an in-depth examination of the industry, encompassing Next Generation Immunotherapy market share, size, trends, and growth predictions. Additionally, the report features an analysis of competitors and regions while spotlighting the most recent developments in the market.
Next Generation Immunotherapy Reports Highlights
What is the size of the Next Generation Immunotherapy Market?
Global Next Generation Immunotherapy Market is projected to grow at a CAGR of around 7.5% during the forecast period, i.e., 2024-29. Some of the key factors propelling the market growth included the rising burden of chronic diseases, increasing research in the area of next-generation drugs, and an increased focus on targeted therapies for certain diseases. Also, the factor majorly affecting the Global Next Generation Immunotherapy Market was the rising prevalence of chronic diseases like asthma, allergic conditions, cancer, and multiple sclerosis.
See more information ODIdea.net
What do the growth prospects and trends look like in the Next Generation Immunotherapy Industry?
Growing Adoption of Chimeric Antigen Receptor (CAR) T-cell Therapy – In recent years, there has been a high demand for chimeric antigen receptor (CAR) T-cell therapy, which has been majorly driven by the rising prevalence of relapsed B-cell acute lymphoblastic leukemia (ALL) and specific non-Hodgkin lymphomas.
Request PDF Sample Report – https://www.marknteladvisors.com/query/request-sample/next-generation-immunotherapy-market.html
What Components are encompassed within Next Generation Immunotherapy Market segmentation?
The report has divided the market into the following segments:
By Type
-Vaccines- Market Size & Forecast 2019-2029F, USD Million
–mRNA Vaccines- Market Size & Forecast 2019-2029F, USD Million
–DNA Vaccines- Market Size & Forecast 2019-2029F, USD Million
–Protein Vaccines- Market Size & Forecast 2019-2029, USD Million
–Others (Viral Vector Vaccines, Nanoparticle Vaccines, etc.)- Market Size & Forecast 2019-2029, USD Million
-Immune Checkpoint Modulators- Market Size & Forecast 2019-2029F, USD Million
-CAR-T Cell Therapy- Market Size & Forecast 2019-2029F, USD Million
-Tumor-Infiltrating Lymphocytes (TILs) Therapy- Market Size & Forecast 2019-2029F, USD Million
-Bispecific Antibodies- Market Size & Forecast 2019-2029F, USD Million
-Oncolytic Virus Therapy- Market Size & Forecast 2019-2029F, USD Million
-Others (Antibody-drug Conjugates, ACE Inhibitors, etc.)- Market Size & Forecast 2019-2029F, USD Million
By Route of Administration
-Intravenous- Market Size & Forecast 2019-2029F, USD Million
-Intratumoral- Market Size & Forecast 2019-2029F, USD Million
-Subcutaneous- Market Size & Forecast 2019-2029F, USD Million
-Oral- Market Size & Forecast 2019-2029F, USD Million
By Therapeutic Area
-Oncology- Market Size & Forecast 2019-2029F, USD Million
-Autoimmune Diseases- Market Size & Forecast 2019-2029F, USD Million
-Infectious Diseases- Market Size & Forecast 2019-2029F, USD Million
-Inflammatory Diseases- Market Size & Forecast 2019-2029F, USD Million
-Others (Neurological Disorders, B-cell Malignancies, etc.) – Market Size & Forecast 2019-2029F, USD Million
By End User
-Hospitals- Market Size & Forecast 2019-2029F, USD Million
-Specialty Clinics- Market Size & Forecast 2019-2029F, USD Million
-Ambulatory Surgical Centres- Market Size & Forecast 2019-2029F, USD Million
-Cancer Research Centres- Market Size & Forecast 2019-2029F, USD Million
By Region
-North America
-South America
-Europe
-Middle East & Africa
-Asia-Pacific.
View Full Report with TOC & List of Figure: – https://www.marknteladvisors.com/research-library/next-generation-immunotherapy-market.html
Who are the Primary Companies or Entities active in the Industry?
The report covers the major market players including:
Bristol Myers Squibb
-Business Description
-Product Portfolio
-Strategic Alliances or Partnerships
-Recent Developments
-Financial Details
-Others
Regeneron Pharmaceuticals
-Business Description
-Product Portfolio
-Strategic Alliances or Partnerships
-Recent Developments
-Financial Details
-Others
MacroGenics
-Business Description
-Product Portfolio
-Strategic Alliances or Partnerships
-Recent Developments
-Financial Details
-Others
AbbVie Inc.
-Business Description
-Product Portfolio
-Strategic Alliances or Partnerships
-Recent Developments
-Financial Details
-Others
Pfizer Inc.
-Business Description
-Product Portfolio
-Strategic Alliances or Partnerships
-Recent Developments
-Financial Details
-Others
Novartis
-Business Description
-Product Portfolio
-Strategic Alliances or Partnerships
-Recent Developments
-Financial Details
-Others
Merck & Co., Inc.
-Business Description
-Product Portfolio
-Strategic Alliances or Partnerships
-Recent Developments
-Financial Details
-Others
AstraZeneca
-Business Description
-Product Portfolio
-Strategic Alliances or Partnerships
-Recent Developments
-Financial Details
-Others
Incyte Corporation
-Business Description
-Product Portfolio
-Strategic Alliances or Partnerships
-Recent Developments
-Financial Details
-Others
Eli Lilly and Company
-Business Description
-Product Portfolio
-Strategic Alliances or Partnerships
-Recent Developments
-Financial Details
-Others
Johnson and Johnson
-Business Description
-Product Portfolio
-Strategic Alliances or Partnerships
-Recent Developments
-Financial Details
-Others.
About Us-
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Submitted your request for a custom report – https://www.marknteladvisors.com/query/request-customization/next-generation-immunotherapy-market.html
Contact Us –
Call: 📞 +1 628 895 8081, + +91 120 4278433
Email: 📧 sales@marknteladvisors.com
Visit to know more: 🌐 https://www.marknteladvisors.com/
Follow MarkNtel For Latest Update⬇️
✔️ https://twitter.com/markntel
✔️https://in.linkedin.com/company/markntel-advisors
✔️ https://www.youtube.com/c/MarkNtelAdvisorsLLP
✔️ https://in.pinterest.com/marknteladvisors/
✔️ https://www.facebook.com/Markntel-Advisors-104380931118025/